Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracorporeal solute and fluid removal via semipermeable membrane" does **not** refer to a specific molecule, receptor, enzyme, transporter, or other canonical therapeutic target. Instead, it describes a **medical procedure**—dialysis—in which blood or another biological fluid is passed outside the body through a device containing a **semipermeable membrane**. This process allows for the selective removal of small and medium-sized solutes (such as urea, creatinine, and electrolytes) and excess water from the blood by diffusion and osmosis across the membrane into a dialysate solution[1][2][5]. The semipermeable membrane itself is typically made of materials like cellulose acetate or synthetic polymers[6], but it is not itself considered a molecular target in pharmacology or drug development. Dialysis can be performed as hemodialysis (using an artificial dialyzer) or peritoneal dialysis (using the patient's own peritoneum as the membrane)[1]. The process relies on physical principles—diffusion for solute movement down concentration gradients; osmosis for water movement; ultrafiltration driven by pressure gradients—not on interaction with any specific protein or molecular entity that would be classified as a "target"[1][2][5]. Because this entry refers to an entire procedure rather than to any single molecule/protein/receptor/target class: > - It should not be treated as a canonical therapeutic target. > - There are no interacting drugs that act directly on this "target." > - There are no relevant biomarkers specific to this concept. > - Safety concerns relate to procedural risks of dialysis rather than molecular targeting. In summary, "Extracorporeal solute and fluid removal via semipermeable membrane" is not an appropriate entry for structured information about drug targets. It describes *how* certain therapies work at an organ/system level but does not correspond to any single actionable biological molecule[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracorporeal solute and fluid removal via semipermeable membrane.